已为您找到该学者10条结果 成果回收站
陈晓光, Yl Li, , Xiaoyi Yang, Jieli Chen, Lei Wang, Ying Wang, Chunling Zhang, Xiaoguang Chen, Mark Katakowski, Tom Mikkelsen, Mci Lu, *, Michael Chopp
,-0001,():
-1年11月30日
We constructed a biologicmaterial composedoffetal ratbrain cells (neurospheres) and adult rat bone marrow stromal cells (MSCs), designated as NMCspheres Adult rats were subjected to 2 hours of middle cerebral artery occlusion (MCAo) and implanted with cultured prelabeled NMCspheres (n=6), neurospheres (n=5) or MSCs (n=6) into the ischemic penumbra at 24 hours after MCAo. Control adult rats (n=10) were subjected to MCAo alone. In vitro within the NMCspheres, MSCs rapidly fonned a process network with intact neural cells compared with a necrotic core within neurospheres alone An in vivo rat corneal assay demonstrated that NMCspheres enhanced angiogenesis compared to MSCs and neurospheres Neurological functional recovery after stroke was enhanced in rats trcated with NMCspheres, compared to rats with neurosphere or MSC treatments by day 7 and day 14 after transplantation. The NMCspheres are a new compositc material that may be employed in the treatment of stroke
stroke, neurosphere, bone marrow stromal cells, a new cell aggregate model, rat
-
135浏览
-
0点赞
-
0收藏
-
0分享
-
154下载
-
0
-
引用
陈晓光, Jieli Chen, , Yi Li, Mark Katakowski, Xiaoguang Chen, Lei Wang, Dunyue Lu, Mei Lu, Subhash C. Gautam, and Michael Chopp, *
Journal of Neuroscience Research 2003, 73, 778-786,-0001,():
-1年11月30日
The present study investigates the induction of neurogenesis, reduction of apoptosis, and promotion of basic fibroblast growth factor (bFGF) expression as possible mechanisms by which treatment of stroke with bone marrow stromal cells (MSCs) improves neurological functional recovery. Additionally, for the first time, we treated cerebral ischemia in female rats with intraveneous administration of MSCs. Female rats were subjected to 2 hr of middle cerebral artery occlusion (MCAo), followed by an injection of 3
marrow stromal cells, subventricular zone, MCAO, cerebral ischemia, apoptosis,, female rat
-
103浏览
-
0点赞
-
0收藏
-
0分享
-
147下载
-
0
-
引用
陈晓光, Xiaoguang Chen, , Mark Katakowski, Yi Li, Dunyue Lu, Lei Wang, Lijie Zhang, Jieli Chen, Yongxian Xu, Subhash Gautam, Asim Mahmood, and Michael Chopp, *
Journal of Neuroscience Research 2002, 69, 687-691 ,-0001,():
-1年11月30日
Treatment of traumatic brain injury (TBI) with bone marrowstromal cells (MSCs) improves functional outcome in the rat. However, the specific mechanisms by which introduced MSCs provide benefit remain to be elucidated. Currently, the ability of therapeutically transplanted MSCs to replace injured parenchymal CNS tissue appears limited at best. Tissue replacement, however, is not the only possible compensatory avenue in cell transplantation therapy. Various growth factors have been shown to mediate the repair and replacement of damaged tissue, so trophic support provided by transplanted MSCs may play a role in the treatment of damaged tissue. We therefore investigated the temporal profile of various growth factors, brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and hepatocyte growth factor (HGF), within cultures of human MSCs (hMSCs) conditioned with cerebral tissue extract from TBI. hMSCs were cultured with TBI extracts of rat brain in vitro and quantitative sandwich enzyme-linked immunosorbent assays (ELISAs) were performed. TBI-conditioned hMSCs cultures demonstrated a time-dependent increase of BDNF, NGF, VEGF, and HGF, indicating a responsive production of these growth factors by the hMSCs. The ELISA data suggest that transplanted hMSCs may provide therapeutic benefit via a responsive secretion of an array of growth factors that can foster neuroprotection and angiogenesis.
marrow stromal cells, traumatic brain injury, neurotrophins, angiogenesis, growth factors
-
60浏览
-
0点赞
-
0收藏
-
0分享
-
115下载
-
0
-
引用
【期刊论文】Cancer chemopreventive and therapeutic activities of red ginseng
陈晓光, Chen Xiaoguang a, *, Liu Hongyan a, Lei Xiaohong a, Fu Zhaodi a, Li Yan a, Tao Lihua b, Han Rui a
Journal of Ethnopharmacology 1998, 60, 71-78,-0001,():
-1年11月30日
Red ginseng extract A and B are the active components of Panax ginseng. Red ginseng is a classical traditional Chinese medicine. Among Chinese herbs, red ginseng has been considered as one of the tonics. Many studies indicated that red ginseng could enhance immune function of the human body. The effects of red ginseng extracts on transplantable tumors, proliferation of lymphocyte, two-stage model and rat liver lipid peroxidation were studied. In a two-stage model, red ginseng extracts had a significant cancer chemoprevention. At 50-400mg/kg, they could inhibit DMBA/Croton oil-induced skin papilloma in mice, decrease the incidence of papilloma, prolong the latent period of tumor occurrence and reduce tumor number per mouse in a dose-dependent manner. Red ginseng extract B could effectively inhibit the Fe 2+/cysteine-induced lipid peroxidation of rat liver microsome, suggesting that red ginseng extract B has a stronger antioxidative effect than that of extract A. The results indicated that red ginseng extracts (50: 400mg/kg) could significantly inhibit the growth of transplantable mouse sarcoma S180 and melanoma B16. Red ginseng extracts A (0.5mg/ml) and B (0.1 and 0.25mg/ml) might effectively promote the transformation of T lymphocyte, but there was no influence on lymphocyte proliferation stimulated by concanavalin A. This suggests that red ginseng extracts have potent tumor therapeutic activity and improve the cell immune system.
Red ginseng, Transplantable tumor, Tlymphocyte proliferation, Tumorigenesis, Lipid peroxidation
-
61浏览
-
0点赞
-
0收藏
-
0分享
-
99下载
-
0
-
引用
陈晓光, Dan Huanga, Yazhuo Zhangb, Xiaoguang Chena, *
Journal of Chromatography B, 784 (2003) 101-109,-0001,():
-1年11月30日
he HPLC columns were 18 kept at 27.8C. The mobile phase was delivered at a flow-rate of 1.0 ml/min, with the following stepwise gradient elution program: A-B (60:40) at 0 min→(40:60) at 30 min→(40:60) at 60 min. Solvent A contained 10 mM tetrabutylammonium hydroxide, 10 mM KH PO and 0.25% MeOH, and was adjusted to pH 6.9 with 1 M HCl. Solvent B consisted of 5.6 mM 24 tetrabutylammonium hydroxide, 50 mM KH PO and 30% MeOH, and was neutralized to pH 7.0 with 1 M NaOH. The 24 calibration curves (r.0.99) of the components in cell extracts were established with their aqueous standards. The average within-day precision for the nine compounds was 0.9%, and the average day-to-day precision was 5.0%. The detection limits (pmol) of the nine reagents were 1.39 (ADP), 4.32 (CTP), 15.5 (dCTP), 2.38 (GTP), 4.42 (UTP), 9.45 (dGTP), 14.6 (dTTP), 2.44 (ATP) and 11.8 (dATP). The recovery of this method for the standards ranged from 82.4 to 120.5%. The results for the detection of nucleotide pools in 16 normal and tumor cell lines were presented. In conclusion, this simplified analytical method enables the simultaneous quantitation of NTP and dNTP in cell or tissue extracts and may represent a valuable tool for the detection of minute alterations of intracellular NTP/dNTP pools induced by anticancer/antiviral drugs and diseases.
Tumor cells, Nucleoside triphosphates
-
54浏览
-
0点赞
-
0收藏
-
0分享
-
307下载
-
0
-
引用